Dr. Cedric Szpirer earned a PhD in molecular biology from Université Libre de Bruxelles.  He was the founder of Delphi Genetics in 2001.  He has been Executive & Scientific Director of Delphi Genetics until beginning of 2021 when the company was sold to Catalent.  He worked as General Manager for Catalent Belgium until June 2021.  He is also the inventor or co-inventor of more than 10 patent families in the field of molecular biology, gene therapy, recombinant productions and DNA engineering and author of several publications in this field.